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There is inadequate research data available on manufactured ZnO nanoparticles. 
Manufactured nanoparticles are widely used in various products and production of 
manufactured nanoparticles is becoming increasingly abundant. Humans are exposed to 
ZnO nanoparticles in products such as sunscreen, toothpaste, and cosmetic products. Due 
to the frequent human contact with nanoparticles, such as ZnO, research on the resulting 
biological effects is highly significant. In this study, we utilized the model organism 
Caenorhabditis elegans (C. elegans) to investigate the effects ZnO nanoparticle exposure 
can have on germ cell apoptosis and key genes involved in the apoptosis pathway. ZnCl2 
(Zn2+) serves as a comparison of toxicity with ZnO nanoparticles in this study. It is 
known that ZnO nanoparticle exposure can have a severe effect on the reproduction 
process in C. elegans, however, it has yet to be tested whether or not ZnO nanoparticles 
affect germ cell apoptotic machinery as a possible mechanism of reproductive toxicity. 
Worms were exposed on an agar medium containing concentrations of ZnO nanoparticles 
and ZnCl2 (range, 6.14×10
-1, 61.4, and 614 µM Zn). ZnO nanoparticles and ZnCl2 both 
significantly increased the number of apoptotic cells as compared to the control in the 
61.4 and 614 µM treatment groups (p<0.05). However, ZnO nanoparticles significantly 
induced nearly 2× more average apoptotic cells in the 61.4 µM treatment than the ZnCl2 
at the same concentration. This relationship was observed in both the bristol N2 wild type 
(N2) and MD701 (bcIs39 [(lim-7)ced-1p::GFP + lin-15(+)]) strains. Genes involved in 
the apoptosis pathway (ced-13, ced-3, ced-4, ced-9, cep-1, dpl-1, efl-1, efl-2, egl-1, egl-
38, lin-35, pax-2, and sir-2.1) were changed in response to ZnO nanoparticle exposure. 
Cep-1/p53 was significantly up-regulated in the 614 µM treatment (p<0.05). In the CEP-
1 loss of function mutant, no significant increases were observed in germ cell apoptosis 
as compared to the control in any treatment group (p>0.05). Therefore, the increased 
apoptosis resulting from ZnO nanoparticle exposure is likely CEP-1 dependent. 
Following exposure, possible ZnO nanoparticles were observed in vivo in the worms 
using transmission electron microscopy, suggesting that the worms can possibly absorb 
the nanoparticles via various routes. 
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INTRODUCTION: PROJECT DESCRIPTION 
Nature of the Problem 
 There is inadequate research data available on manufactured ZnO nanoparticles 
(NPs) and effects that could result from prolonged exposure on humans and other life 
forms.  This is alarming due to the fact of how frequently humans are exposed to ZnO 
NPs and how increasingly abundant ZnO NPs are becoming in various products.  My 
goal is to discover what potential consequences may arise in the future after such 
increasingly recurrent exposure to ZnO NPs.  
 Manufactured NPs are particles that have one or more dimensions of less than 100 
nm (Wang, Wick, & Xing, 2009; SCENIHR (Scientific Committee on Emerging and 
Newly-Identified Health Risks), 21-22 June 2007).  NPs are produced in metric tons per 
year and production is expected to increase over the next decade (Ma, Bertsch, Glenn, 
Kabengi, & Williams, 2009).  In particular, ZnO NPs are used in products that most 
humans come into contact with on a daily basis such as, toothpaste, sunscreens, cosmetics 
or beauty products, and textiles (Wang et al., 2009).  Due to expected increases of 
manufactured NPs and the frequency of human contact with NPs, research on biological 
effects of NPs like ZnO is of extreme importance.  It is also important to understand how 
the safety and health of humans may be impacted as a result of prolonged exposure to 
ZnO NPs.  The U.S. Environmental Protection Agency deemed nanoparticle research on 
both aquatic and terrestrial systems to be of future priority (U.S. Environmental 
Protection Agency, 2005 Office of Research and Development, Washington, DC). 
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Literature Review 
There have been a few studies assessing the toxicological effects of manufactured 
ZnO NPs in the free living nematode Caenorhabditis elegans (C. elegans).  One study 
compared the toxicological effects of manufactured ZnO NPs to that of ZnCl2 (Ma et al., 
2009).  Endpoints evaluated were lethality, behavior (movement), reproduction.  Four 
day old, wild-type N2 strain C. elegans were used for testing and maintained at 20°C.  
Average size of particles in the ZnO NP suspension used was determined to be 1.5 nm by 
transmission-electron microscopy. All metal solutions were made in buffered and 
unbuffered K-medium and all tests were performed in an aqueous medium. For the 
lethality test, worms were exposed to 5-6 concentrations of ZnO and ZnCl2 (range, 325-
1,625 mg Zn/L), for 24 hours. They found that as concentrations of Zn increased, 
mortality increased (10-100%), whereas mortality in control worms was less than 10% at 
all times (Ma et al., 2009).  Concentrations used were fairly high (range, 325-1,625 mg 
Zn/L) and ZnO NPs were proven toxic.  For movement or behavior, concentrations tested 
included 5-6 concentrations of ZnO and ZnCl2 ranging from 50-1,000 mg Zn/L.  Worms 
were exposed to these various concentrations for 4 hours at 20°C.  Movement was 
tracked 1 hour after exposure by a video camera and computer equipped with tracking 
software.  Average movement per worm per second was calculated using computer 
software.  Control worms had an average movement speed of 3.5 μm per second.  Results 
showed that for ZnO and ZnCl2 movement responses occurred across one order of 
magnitude in concentration, from 100-20% of the control movement (Ma et al., 2009). To 
test reproductive effects a 72 hour assay was used, consisting of 5 concentrations of ZnO 
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NPs or ZnCl2 ranging from 10-200 mg Zn/L, and a control.  One adult worm was placed 
in each 1 ml of test solution for 72 hours of exposure.  Following exposure, numbers of 
offspring were recorded.  Average number of offspring in control was 122.  A significant 
decrease in reproduction was observed as ZnO NP or ZnCl2 concentration increased (10–
200mg Zn/L).  Also, when compared to lethality or movement, reproduction was affected 
at much lower concentrations.  For reproduction, the concentration causing a 50% 
decrease in the number of offspring as compared to control was 46 mg Zn/L for ZnO NPs 
and 59 mg Zn/L for ZnCl2 (Ma et al., 2009).   
Authors proposed that ZnO NPs may have dissolved to Zn2+ in the test medium to 
activate toxicity (Ma et al., 2009). More testing will need to be done to test this theory. 
ZnCl2 was found to be more toxic in the unbuffered than the buffered K-medium. This is 
due to the fact that free Zn2+ ions are the main cause of ZnCl2 toxicity. Therefore, ZnCl2 
toxicity in the buffered K-medium decreased due to the decrease in free Zn2+ ion 
concentration, which in turn was caused by complexation of the Zn with other species in 
the solution (Ma et al., 2009).  All resulting data from this study shows ZnO NP exposure 
to be toxic and resulting effects are significant.  Therefore, toxicity of ZnO NPs should be 
further assessed.   
 Another study was also performed to determine whether metal oxide NPs were 
toxic to C. elegans.  This study tested effects of ZnO NPs along with its bulk counterpart 
and reagent-grade ZnCl2 (Wang et al., 2009).  The stock suspensions of nanoparticulate 
and bulk ZnO used was 16.3 mg L-1.   Measured diameter of ZnO bulk particles was 532 
nm.  This study used wild type N2 strain of C. elegans at L1 stage.  There were four 
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endpoints assessed which included lethality, length of worm, number of eggs inside the 
worm body and offspring per worm.  Tested concentrations were 0.4, 0.8, 1.6, 4.1, 6.1 
and 8.1 mg L-1 for nanoparticulate and bulk ZnO, and 0.7,1.4, 2.7, 6.8,10.2 and 13.6 mg 
L-1 for ZnCl2 (Wang et al., 2009).  Each test was carried out in ultrapure water.  To test 
for lethality, approximately 30 L1 juveniles were transferred to petri plates containing 
various concentrations of tested particles along with a loopful of pelleted bacteria as food.  
Exposure lasted for 24 hours.  Surviving worms were counted using a dissecting 
microscope.  Results showed that LC50 values (lethal concentration at which 50 percent 
of the organisms die during testing) calculated were, respectively, 2.2, 2.3 and 2.9 mg L-1 
for nanoparticulate and bulk ZnO and ZnCl2 (Wang et al., 2009).  ZnO NPs, caused 
lethality when exposed for 24 hours. It is also notable that the ZnO NP concentrations 
tested were considerably low and yet still caused lethality.  To test both growth and 
reproductive effects, L1 worms were exposed under the same conditions as lethality test 
worms, these worms were exposed for 5 days as opposed to 24 hours (Wang et al., 2009).  
Results revealed that exposure to 1.6 mg L-1 and 4.1 mg L-1 for both ZnO NPs and 
bulk ZnO significantly reduced the growth of C. elegans, number of eggs inside the 
worm and offspring per worm.  Effect on growth and number of eggs inside the worm 
was not significantly different between ZnO NPs, bulk ZnO and ZnCl2.  However, the 
number of offspring per worm exposed to ZnO NPs was significantly less than that of the 
bulk ZnO at 0.8 and 1.6 mg L-1 (Wang et al., 2009).  These experiments were carried out 
in the dark, therefore, production of reactive oxygen species (ROS) were probably a 
minimal cause of toxicity. According to this study, effects seen by ZnO NPs could have 
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been partly caused by the release of dissolved Zn2+.  It could not fully be determined that 
toxicity of the nanoparticles was caused by dissolved Zn2+ alone and there may be a 
nanoparticle-specific toxic mechanism (Wang et al., 2009).  These results support the fact 
that more research on ZnO NPs is necessary because ZnO NPs have a significant 
negative impact on the C. elegans reproduction.  It is obvious that NPs are toxic and 
exposure to NPs should be kept to a minimum if possible, especially with NPs such as 
ZnO, because even with exposure to low concentrations of ZnO NPs, harmful effects are 
evident.    
An additional study examined toxicity of ZnO NPs at environmentally relevant 
concentrations in C. elegans (Wu et al., 2013).  NPs used were 30 nm in size and each 
test involved prolonged exposure of the C. elegans from the L1 stage to adult 
(approximately 3 days). Endpoints assessed were lethality, growth, locomotion/behavior, 
and reproduction.  Stock suspension concentrations were prepared in K medium and 
concentrations of the metal oxide NPs used were 0.0005, 0.005, 0.05, 0.5, 5, 10, and 50 
μg/L. C. elegans used were of the N2 wild type strain. Tests were carried out in 12-well 
sterile tissue culture plates in the presence of food (Wu et al., 2013). 
Results for the lethality test revealed that prolonged exposure (L1-adult) to 50 
μg/L of ZnO NPs significantly increased the mortality of the worms.  Survival was not 
obviously affected with prolonged exposure to 0.0005-10 μg/L ZnO NPs.  Results for the 
growth test, which were determined by length of worm, were found to be exactly the 
same as the results of the lethality test.  No affect was seen with prolonged exposure to 
0.0005-10 μg/L of the examined metal oxide NP.  However, when exposed to 50 μg/L 
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ZnO NPs, body lengths of the worms were significantly shortened. Reproduction toxicity 
effects were assessed using brood size as an endpoint. Prolonged exposure to 0.0005-0.05 
μg/L ZnO NPs did not affect brood size of the worms.  Prolonged exposure to 0.5–50 
μg/L ZnO NPs significantly decreased brood size of nematodes compared to control. 
Prolonged exposure to 0.05–50 μg/L of ZnO NPs caused a significant decrease in the 
number of head thrashes and body bends of worms compared to control.  Finally, 
prolonged exposure to 0.0005–0.005 μg/L of ZnO NPs did not affect the behavior of the 
worms. In all endpoints assessed including lethality, growth, reproduction, and behavior, 
ZnO NPs were proven to be most toxic and caused the most significant effects (Wu et al., 
2013). This study suggests that oxidative stress is one mechanism behind toxicity of ZnO 
NPs. This was confirmed by a reactive oxygen species (ROS) production assay.  It was 
found that ROS production was significantly correlated with lethality, growth, 
reproduction, body bends and head thrashes. To further confirm that oxidative stress 
induced toxicity, they treated ZnO NP exposed worms with antioxidants (10 mM 
ascorbate). Post-treatment of antioxidants after prolonged exposure to 50 μg/L ZnO NP, 
significantly suppressed increases in mortality, decreases in body length, body bends, and 
head thrashes, reduction in brood size, and the induction of ROS production (Wu et al., 
2013). Interestingly, this study (Wu et al., 2013) used environmentally relevant 
concentrations. Thus, even at concentrations which are environmentally relevant, ZnO 
NPs cause adverse effects.   
Data and results provided by research that has been done so far involving ZnO 
NPs and C. elegans is alarming and draws concern.  All literature reviewed indicates that 
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exposure to ZnO NPs at various concentrations, including environmentally relevant 
concentrations can have consequences in C. elegans. When compared to the control, 
effects of ZnO NP exposure included increased mortality, decreased number of offspring 
produced, decreased number of eggs inside the body, reduction in body length, and 
decrease in the number of body bends and head thrashes.  ZnO NPs have toxic effects 
and are harmful to organisms when they are exposed for a prolonged period of time.  
Production of manufactured ZnO NPs is escalating and this trend is expected to continue 
(Ma et al., 2009).  With humans being exposed daily to ZnO NPs in products such as 
toothpaste, sunscreen, cosmetics, and textiles, more research on ZnO NPs needs to take 
place.   
Therefore, it is of importance to reveal effects as well as underlying toxicity 
mechanisms of ZnO NPs so that the manufacture and use of these NPs can be regulated 
accordingly.  Recently C. elegan studies using ZnO NPs have assessed endpoints such as 
lethality, growth, reproduction, and behavior for toxicological evaluation. These studies 
described above indicate ZnO NPs cause a reduction in offspring and the number of eggs 
(Ma et al., 2009; Wang et al., 2009; Wu et al., 2013).  However, to my knowledge, no 
one has yet to test whether or not ZnO NPs affect germ cell apoptotic machinery 
(programmed cell death) as a mechanism of reproductive toxicity.   
  
 
 
Hypothesis 
I hypothesize that exposure to ZnO NPs will lead to increased germ cell 
apoptosis, induce more apoptosis than Zn2+ (ZnCl2), and affect key genes in the apoptosis 
pathway. 
Objectives 
 Evaluate effects of ZnCl2 and ZnO NP exposure on germ cell apoptosis in 
Caenorhabditis elegans 
 Determine effects of ZnCl2 and ZnO NP exposure on expression of genes 
involved in the apoptosis pathway  
METHODS/MATERIALS 
Organism 
Caenorhabditis elegans are free-living nematodes found in aqueous environment 
of soil ecosystems and play a key role in nutrient cycling (Wang et al., 2009; Wu et al., 
2013).  They are ideal model organisms because their complete genome has been 
sequenced, they have 60-80% homology with the human genome, a short life cycle 
(approximately 3 days), and life span (approximately 2-3 weeks), and are also easily 
cultured and maintained.  Due to their translucent bodies, developmental processes, such 
as the stage of growth, and number of eggs inside the body, can be easily monitored via 
microscope (Fig. 1).  As a food source, C. elegans use Escherichia coli (E. coli OP50), 
which is easily cultured.  C. elegans are used as great models for toxicological studies for 
an extensive variety of environmental toxicants (Leung et al., 2008).  Recently there have 
been a few studies evaluating the toxicity of various NPs including ZnO NPs on C. 
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elegans (Ma et al., 2009; Ma et al., 2011; Wang et al., 2009; Wu et al., 2013).  The life 
cycle of C. elegans consists of four larval stages (L1-L4) before reaching adult stage (Fig. 
2).  Due to the high level of conserved genes and gene pathways from C. elegans to 
humans, data collected in C. elegans studies can be indicative for higher organisms.  C. 
elegans can be hermaphrodites, males, and females, therefore they can self- or cross-
fertilize.  
In this study 3 strains of C. elegans were used: Bristol N2 wild type (N2), MD701 
(bcIs39 [(lim-7)ced-1p::GFP + lin-15(+)]), and TJ1(cep-1(gk138) I). N2 hermaphrodites 
were used to ensure that worms and their offspring are genetically identical.  The MD701 
strain allows visualization of apoptotic cells. The ced-1 gene is involved in apoptosis. 
This gene was upregulated when germ cells undergo apoptosis, working as a signal to 
promote the engulfment of cell corpses by phagocytic sheath cells. As CED-1 expresses 
on the cell membrane, apoptotic cells can be visualized as a green fluorescent circle in the 
loop region of the MD701 gonad (Gartner, Boag, & Blackwell, 2008). The TJ1 strain is a 
CEP-1 loss of function mutant used to determine if CEP-1 is needed in the ZnO NP 
induced apoptosis.  
Germline Apoptosis 
 There are 2 categories of C. elegans germline apoptosis. During normal oogenesis 
many early germ cells undergo apoptosis. This process is significant to the reproductive 
process and is broadly conserved from worms to mammals.  Nearly 50% of 
predetermined oocytes undergo apoptosis under normal conditions. These cells serve as a 
population of nurturing cells, providing mature oocytes with cytoplasmic components 
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(Gartner et al., 2008; Gumienny, Lambie, Hartwieg, Horvitz, & Hengartner, 1999; Hall & 
Altun, 2008). Once the nurse cells have been utilized apoptosis is activated producing a 
nurse cell corpse which is engulfed by neighboring somatic gonad sheath cells (Fig. 3a) 
(Gumienny et al., 1999). The second category is germline apoptosis induced by 
environmental stressors such as DNA damage or pathogenic infection. Environmental 
stress can cause a significant increase in apoptosis as compared to the normal range. The 
reproductive process can be severely affected by such increases in apoptosis, reducing the 
number of mature oocytes and thus reducing the number of offspring (Ruan et al., 2012).  
Apoptosis normally occurs within the transitional region (mitosis to meiosis) or gonadal 
loop (Fig. 3a). As genetically unsuitable cells pass through the gonad loop or death zone 
they undergo apoptosis to prevent further maturation into oocytes (Hengartner, 1997). 
Normally, in wild type C. elegans hermaphrodites, approximately 150 germ cells will 
undergo programmed cell death but only 0-3 corpses will be observed any time 
throughout the first 3-4 days of adulthood (Gumienny et al., 1999).  
Apoptosis Pathway 
Many genes involved in the main apoptosis pathway have human homologs (fig. 
3b) (Hengartner, 1997). Cep-1 promotes DNA damage-induced apoptosis (WormBase, 
a). This gene increases transcription of egl-1 and ced-13 which are both similar to BH3 
(Bcl-2 homology domain) in mammals, cell death activators. Both EGL-1 and CED-13 
interact directly with CED-9, an anti-apoptotic protein, which encodes for the cell death 
inhibitor Bcl-2 in mammals, and inhibit its transcription, inducing the release of CED-4 
and causing activation of CED-3 (caspase). Ced-4 encodes for a protein similar to Apaf-1 
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in humans and regulates ced-3 activity which is required for carrying out apoptosis 
(WormBase, b; WormBase, c). Lin-35 encodes for Rb, the retinoblastoma protein, and 
promotes physiological apoptosis by inhibiting transcription of ced-9 (Gartner et al., 
2008). PAX-2 and EGL-38 are Pax-family proteins that work to suppress the apoptosis 
by increasing transcription of ced-9 (Gartner et al., 2008). Dpl-1 encodes for DP (protein 
transcription factor) in mammals and works along with efl-1/2, which encodes for the 
transcription factor E2F in mammals. DPL-1, Rb, and E2F seem to work together to 
increase CED-4 and CED-3, therefore promoting germ cell apoptosis (Gartner et al., 
2008) (Table 1). 
 
 
 
 
Fig. 1. Translucent body, clearly showing internal egg hatching (arrows). 
This indicates the outside environment is stressful. 
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Fig 2. Life cycle of C. elegans 
http://www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro.htm 
Fig. 3a. Gonad arm and germline apoptosis. A) Gonad arm of adult 
hermaphrodite. B) Cross section of loop region showing apoptotic 
cell being engulfed by sheath cell (Gartner et al., 2008). 
http://www.wormbook.org/chapters/www_germlinesurvival/germlinesurvival.html 
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Gene 
Symbol 
Locus Tag Gene 
Description 
Function Reference 
ced-3 C48D1.2 CEll Death 
abnormality 
caspase protein and initiates 
apoptosis 
(Bailly & Gartner, 2013; Denning, Hatch, & 
Horvitz, 2013) 
ced-4 C35D10.9 CEll Death 
abnormality 
Apaf-1 homolog  (Pourkarimi, Greiss, & Gartner, 2012; Zou, 
Henzel, Liu, Lutschg, & Wang, 1997) 
ced-9 T07C4.8 CEll Death 
abnormality 
Bcl-2 homolog; mitochondrial 
fusion and fission; inhibits 
apoptosis 
(Pourkarimi et al., 2012) 
ced-13 R09F10.9 CEll Death 
abnormality 
BH3-only domain (Schumacher et al., 2005) 
cep-1 F52B5.5 C. Elegans P-53-
like protein 
p53 tumor suppressor (Derry, Putzke, & Rothman, 2001) 
dpl-1 T23G7.1 vertebrate 
transcription 
factor DP-Like 
DP ortholog (Ceol & Horvitz, 2001; Chi & Reinke, 
2009) 
efl-1 Y102A5C.18 E2F-like 
(mammalian 
transcription 
factor) 
E2F homolog 
 
(Brodigan, Liu, Park, Kipreos, & Krause, 
2003) 
efl-2 Y48C3A.17 E2F-LIKE 
(mammalian 
transcription 
factor) 
E2F homolog (Boxem & van den Heuvel, 2002) 
egl-1 F23B12.9 EGg Laying 
defective 
BH3-only domain (Schumacher et al., 2005) 
egl-38 C04G2.7 EGg Laying 
defective 
encodes a protein part of the 
same family as pax-2,5,8; 
required for cell fate in 
hermaphrodites  
(Chamberlin et al., 1997) 
lin-35 C32F10.2 abnormal cell 
LINeage 
Retinoblastoma (Rb) ortholog (Ceol & Horvitz, 2001) 
pax-2 K06B9.5 PAX (Paired 
box) 
transcription 
factor 
transcription factor (Park, Jia, Rajakumar, & Chamberlin, 2006) 
sir-2.1 R11A8.4 yeast SIR related aging and lifespan (Kenyon, 2010; Ludewig et al., 2013) 
Table 1: Description of 13 genes involved in the apoptosis pathway 
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                                                                                                                                     Fig. 4. Magnified image of eggs (brackets) inside the body of C. 
elegans. Worms will be lysed and eggs will be released. 
 
 
 
Fig. 3b.  Apoptosis pathway. Includes core apoptotic components 
(CED-9, CED-4, CED-3). In parenthesis are the human homologs 
that correspond with the C. elegans genes (Gartner et al., 2008). 
http://www.wormbook.org/chapters/www_germlinesurvival/germlinesurvival.html 
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Fig. 5. Arrows indicate apoptotic cells. A. and C. show gonad arms without 
fluorescence. B. and D. show gonad arms with fluorescence after SYTO 12 assay 
(Shaham & ed., January 2, 2006). 
Fig. 6. Gonad arm of C. elegan with apoptotic cells 
(green fluorescent circles). MD701 strain 
 
 
Statistical Analysis 
For statistical analysis, the IBM SPSS Statistics 20 software for Windows 7 was 
used.  To determine statistical differences between treatment and control groups in 
apoptosis cell counts and gene expression fold changes the statistical test analysis of 
variance (ANOVA) was used. If treatment groups were statistically significant at p < 0.05 
level, least significant difference (LSD) multiple comparisons were carried out to 
compare means among groups.  
Project Relevance 
Uncovering possible damaging effects that human exposure to ZnO NPs could 
have in the future would yield great contributions to the medical field, the environment, 
and to the public.  Being that C. elegans have 60-80% homology with the human 
genome, findings will be useful for human extrapolations.  Metal oxide NPs are not 
biodegradable and consequences of this are not known (Wang et al., 2009).  Therefore, 
this study is also significant to environmental organisms including terrestrial and aquatic 
animals. It will also provide evidence of harmful effects of NPs which will help agencies, 
such as the Environmental Protection Agency, better regulate production of NPs such as 
ZnO NPs.   
RESULTS 
MD701 (bcIs39 [(lim-7)ced-1p::GFP + lin-15(+)]) strain 
 ZnO NP worms had an average of 1.5, 4.3, and 2.7 engulfments for the control, 
61.4 μM, and 614 μM treatments, respectively. ZnCl2 worms had an average of 1.4, 2.5, 
and 2.6 engulfments for the control, 61.4 μM, and 614 μM treatments, respectively.  Both 
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the 61.4 and 614 μM groups for ZnO NP and ZnCl2 were found to be statistically 
significant from the control. ZnO NP 61.4 μM concentration significantly induced more 
apoptosis than the 614 μM ZnO NP concentration. Also apoptosis in this concentration 
was significantly increased compared to the ZnCl2 61.4 and 614 μM groups (Fig. 7, 8).  
Results indicate, based on the 61.4 μM ZnO NP group, that ZnO NPs are more potent 
than free Zn2+ (ZnCl2), in terms of apoptosis induction at specific concentrations. 
 
 
 
 
 
Fig. 7. Average number of engulfments per gonad arm after L1-adult dose (72 
hrs). MD701 (bcIs39 [(lim-7)ced-1p::GFP + lin-15(+)]) strain. Different letters 
denote statistically significant differences. Error bars indicate standard 
deviations of 3 individual experiments (each consisting of 10 worms). 
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614 μM ZnO NP 
NP 
Control 
61.4 μM ZnO NP Control 
Fig. 8. ZnO NP 72 hr dose. Apoptotic cells appear as green fluorescent 
circles indicated by white arrows. MD701 (bcIs39 [(lim-7)ced-1p::GFP + 
lin-15(+)]) strain. 
614 μM ZnCl2  61.4 μM ZnCl2 
Fig. 9. ZnCl2 72 hr dose. Apoptotic cells appear as green 
fluorescent circles indicated by white arrows. MD701 (bcIs39 
[(lim-7)ced-1p::GFP + lin-15(+)]) strain. 
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SYTO 12 Assay on N2 worms 
 ZnO NP treated N2 worms had an average of 1.6, 1.7, 4.6, and 2.8 apoptotic cells 
for the control, 6.14×10-1 μM, 61.4 μM, and 614 μM treatments, respectively. The 
6.14×10-1 μM group showed no significant difference compared to control. The 61.4 and 
614 μM treatments significantly increased the number of apoptotic cells as compared to 
control. The number of apoptotic cells in the 61.4 μM group was significantly higher than 
the 614 μM treatment group (p<0.05). These results are comparable to the findings using 
the MD701 strain, i.e. the wild-type N2 worms subjected to the SYTO 12 assay displayed 
approximately the same average number of apoptotic cells in all groups as in MD701 
strain worms (Fig. 10, 11).  ZnCl2 N2 worms had an average of 1.6, 1.6, 2.4, and 2.5 
apoptotic cells for the control, 6.14×10-1 μM, 61.4 μM, and 614 μM treatments, 
respectively. The 6.14×10-1 μM group showed no significant difference compared to 
control, the 61.4 and 614 μM treatments significantly increased the number of apoptotic 
cells as compared to control. Unlike the ZnO NP treatments, no significant difference 
was found between the 61.4 and 614 μM treatments (Fig. 10, 12).                                                                                                         
 Comparing the ZnO NP treatments to the ZnCl2 treatments, no significant 
difference was found between the controls or the 614 μM treatment groups.  However, 
apoptosis in the 61.4 μM ZnO treatment group was significantly higher than apoptosis in 
the 61.4 μM ZnCl2 treatment group.  To determine if the observed increases in apoptosis 
from the ZnO NPs is CEP-1/p53 dependent, we performed the experiment using the 
TJ1(cep-1(gk138) I) strain.  The CEP-1/p53 mutant worms had averages of 1.6, 1.6, 2, 
and 1.7 apoptotic cells per gonad arm for the control, 6.14×10-1 μM, 61.4 μM, and 614 
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μM ZnO NP treatments, respectively. Results showed no statistically significant 
differences between groups (p>0.05). Findings suggest that observed apoptosis follows a 
CEP-1/p53 dependent pathway, as the number of apoptotic cells showed no increase in 
the CEP-1/p53 mutant strain (Fig. 13, 14). 
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Fig. 10. Average number of apoptotic cells per gonad arm after L1-adult 
stage (72 hrs) dosing. SYTO 12 staining N2 strain. Different letters 
denote statistically significant differences. Error bars indicate standard 
deviations of 3 individual experiments (each consisting of 10 worms). 
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614 μM ZnCl2  61.4 μM ZnCl2 
Fig. 12. ZnCl2 (72 hr dose). SYTO 12 assay. Apoptotic cells appear as 
solid green dots indicated by white arrows. 
Fig. 11. ZnO NP (72 hr dose). SYTO 12 assay. Apoptotic cells appear as 
solid green dots indicated by white arrows. 
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614 μM ZnO NP 
Control 
NP 
Control 
NP 
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Fig. 13. Average number of apoptotic cells per gonad arm after L1-adult stage 
(72 hrs) dosing. (SYTO 12) TJ1 strain. Different letters denote statistically 
significant differences. Error bars indicate standard deviations of 3 individual 
experiments (each consisting of 10 worms). No significant difference among 
control or any of the treatments. 
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Gene Expression 
ZnO NP Treatments 
There are 13 genes involved in the main apoptosis pathway in C. elegans (ced-13, 
ced-3, ced-4, ced-9, cep-1, dp-1, efl-1, efl-2, egl-1, egl-38, lin-35, pax-2, sir-2.1) (Fig. 3b; 
Table 1). The core apoptotic machinery involved in the apoptosis process are ced-9, ced-
4, and ced-3. As described earlier, the other 10 genes work to either inhibit or promote 
614 μM ZnO NP 61.4 μM ZnO NP 
Control 6.14×10-1 μM ZnO NP 
Fig. 14. ZnO NP (72 hr dose). SYTO 12 assay. Apoptotic cells 
appear as solid green dots indicated by white arrows. TJ-1 strain. 
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regulation of these 3 core genes. Ced-9 is an apoptosis inhibitor, while ced-4 and ced-3 
promote apoptosis. In the 614 μM treatment, cep-1, egl-1, lin-35, efl-2 and sir-2.1 were 
all significantly disregulated compared to the control (p<0.05) (Fig. 15). In the 61.4 μM 
treatment there was no statistically significant difference compared to the control. In the 
6.14×10-1 μM treatment egl-1 was significantly up-regulated (p<0.05). Egl-1, ced-13, and 
lin-35 are all up-regulated in both the 61.4 and the 614 μM treatments. Up-regulation of 
these 3 genes all reduce transcription of ced-9 (apoptosis inhibitor) in the apoptosis 
pathway.  Efl-1/2, and dp-1 are up-regulated in all 3 treatment groups which promote the 
transcription of ced-4 and ced-3. In the apoptosis pathway ced-4 promotes transcription 
of ced-3, which initiates apoptosis (Fig. 3b).  These results all suggest that genes respond 
to ZnO NP exposure by inducing apoptosis in C. elegans.  
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Fig. 15. qRT-PCR data. ZnO NP dose 
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ZnCl2 Treatments 
 Following ZnCl2 treatments, the average fold changes for all 13 tested genes are 
all lower than 1 fold. Only three genes, ced-4, egl-38, and lin-35 display significant down 
regulations compared to control. Ced-4 is part of the core apoptotic machinery and lin-35 
promotes physiological apoptosis, yet both were significantly down-regulated (Gartner et 
al., 2008). In addition, the express of cep-1 was not changed comparing with control (p > 
0.05).  
 
 
Microscope characterization of ZnO NPs 
 Using Image J software, ~400 ZnO nanoparticles total were measured from 4 
different TEM images of the 61.4 µM concentration (~100 particles from each, Fig. 17 
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Fig. 16. qRT-PCR data. ZnCl2 24 hr dose 
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A.). The average size was determined to be 17.9±7.3 nm for the 61.4 µM concentration 
ZnO NPs (Fig. 18). A Malvern Zetasizer utilizing dynamic light scatter, determined the 
average hydrodynamic diameter of the 61.4 µM concentration ZnO nanoparticles to be 
721±109.5 nm.  The 614 µM concentration displayed large amounts of particle 
aggregates (Fig. 17 C, D). 
 
Fig. 17. A) TEM image of ZnO NPs (61.4 μM). B) Ultrapure water control.      
C, D) TEM images of ZnO NP aggregates (614 μM). 
A B 
C D 
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TEM Imaging of ZnO Nanoparticles In vivo 
 N2 worms were dosed at 61.4, and 614 μM ZnO NP. Both treatment and control 
worms were dosed from L1 to adult stage for 72 hrs. Following fixation and staining 
protocol, worms were fixed, sectioned into thin 60-90 nm sections, and stained. Upon 
observation of the worms using the TEM, we found what could be the ZnO NPs in vivo 
in a 61.4 μM treatment worm. The nanoparticulate was found in the gonad region of the 
worm as well as under the cuticle of the worm body (Fig. 19 A, C, D).  No NPs were 
observed in vivo in any region of the control worms (Fig. 19 B). NPs could possibly be 
taken up through the worm cuticle or via the ingested E. coli (Fig. 20). 
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Fig. 18. Frequency histogram of ZnO nanoparticle size distribution.  This 
information was gathered from the Image J analysis data. 
28 
 
 
 
 
 
 
A B 
C 
Fig. 19. (Nanoparticulate indicated by red arrows). A) TEM image of possible 
nanoparticulate in the gonad region of a 61.4 µM treatment worm. B) TEM image of 
the gonad region of a control worm with no observed nanoparticulate. C) TEM image 
of possible nanoparticulate under the cuticle region of a 61.4 µM treatment worm, 
black arrow indicates worm cuticle. D) Same as image C, but at a higher magnification. 
 
D 
 
 
 
 
 
DISCUSSION 
 SYTO 12 assay and the experiments involving the MD701 strain indicate that 
concentrations of 61.4 and 614 μM ZnO NPs induce germ cell apoptosis.  ZnO NP 
induced average apoptotic cells, as observed in both MD701 and N2 strains, were nearly 
2× higher in the 61.4 μM treatment compared to ZnCl2 induced apoptosis at the same 
concentration. Average number of apoptotic cells in the 614 μM treatment was 
approximately the same for both ZnO NPs and ZnCl2.  Lower counts of apoptotic cells in 
the 614 μM ZnO NP treatment group may be attributed to particle aggregation (Fig. 17 C, 
D). The TJ-1 (CEP-1 knock-out mutant) strain was used to determine if the increase in 
apoptosis caused by ZnO NPs was CEP-1/p53 dependent or not. TJ-1 treatment worms, 
Fig. 20. TEM image of worm gut filled with E. coli.  
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showed no significant increase in apoptosis in any group as compared to control 
following ZnO NP exposure. This suggests that germline apoptosis observed in the 
previous ZnO NP apoptosis assays is occurring via the CEP-1/p53 dependent pathway.  
To investigate the genetic regulation for increased apoptosis from ZnO, we performed 
qRT-PCR to check gene expression of worms treated with 6.14×10-1, 61.4, and 614 μM 
ZnO NPs. Cep-1 was significantly up-regulated in the 614 μM treatment group. This 
finding supports the evidence obtained using the TJ-1 strain, that ZnO induced germ cell 
apoptosis is occurring via the CEP-1/p53 dependent pathway.  Cep-1 is a tumor 
suppressor protein which encodes for p53 in humans (Gartner et al., 2008). Apoptosis 
which is DNA damage related may therefore show an up-regulation of the tumor 
suppressor protein CEP-1/p53, as in the 614 μM treatment. According to the apoptosis 
pathway, results suggest that all 3 concentrations of ZnO NPs induced apoptosis, which is 
consistent with the fact that egl-1, ced-13, and lin-35 were all up-regulated in both the 
61.4 and the 614 μM treatments. As described earlier, in the apoptosis pathway, both 
EGL-1 and CED-13 interact directly with CED-9, an anti-apoptotic protein, which 
encodes for the cell death inhibitor BCL-2 in mammals, and inhibit its transcription, 
inducing the release of CED-4 and causing activation of CED-3 (caspase) (WormBase, b; 
WormBase, c). Lin-35, which was also up-regulated, encodes for Rb, the retinoblastoma 
protein, and promotes physiological apoptosis by inhibiting transcription of ced-9 
(Gartner et al., 2008). In addition, efl-1/2, and dp-1 were up-regulated in all 3 treatment 
groups and as mentioned earlier, dpl-1 encodes for Dp (dimerization partner protein) in 
mammals and works along with efl-1/2, which encodes for the transcription factor E2F in 
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mammals. DPL-1, Rb, and E2F seem to work together to increase CED-4 and CED-3 
expression, therefore promoting physiological germ cell apoptosis (Gartner et al., 2008).  
ZnCl2 gene expression results were very different compared to the ZnO NP data. 
Following ZnCl2 treatments, the average fold changes, for all 13 tested genes, were all 
lower than 1 fold. Only three genes ced-4, egl-38, and lin-35 displayed significant down 
regulations compared to control (p<0.01). Ced-4 is part of the core apoptotic machinery 
and lin-35 promotes physiological apoptosis, yet both were significantly down-regulated 
(Gartner et al., 2008). Also, the express of cep-1 was not changed comparing with control 
(p > 0.05) (Fig. 16). In contrast, the ZnO NP gene expression data showed a significant 
increase in cep-1, suggesting that the apoptosis observed in the worms following ZnCl2 
exposure is likely cep-1 independent. Overall, these findings may suggest that the core 
genes in apoptosis pathway were in general not changed or only marginally down-
regulated under ZnCl2 exposures.  The apoptosis pathway was suppressed following 
exposure to ZnCl2. In all of these experiments ZnCl2 served as a comparison of effects of 
free Zn2+ to the ZnO NPs due to the fact that ZnCl2 is highly soluble in water and when 
dissolved will create free Zn2+ in solution. Worms exposed to ZnO NPs had higher 
increases of apoptosis than worms exposed to ZnCl2.  Key genes in the apoptosis 
pathway were affected, following ZnO NP exposure, in a way that suggests that the 
apoptosis pathway was activated and apoptosis was induced. This was not the case for 
worms exposed to ZnCl2. Therefore, based on the data from experiments involving 
ZnCl2, we can conclude that the observed increased apoptosis caused by ZnO NPs was 
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not attributed to free Zn2+ alone.  The NP form of Zn was found to be more toxic than the 
free Zn2+ from ZnCl2.  
 Using the TEM, several images of 61.4 µM ZnO NPs were taken (Fig. 17 A). 
After analyzing ~400 various ZnO NPs using Image J software, the average size of the 
ZnO NPs was determined to be 17.9±7.3 nm (Fig. 18). In contrast, the average 
hydrodynamic diameter of the ZnO nanoparticles was determined to be 721±109.5 nm 
(n=30) by dynamic light scattering.  The zetasizer size determination of the ZnO NPs is 
larger than that of the TEM method of measurement. This was the case for other studies 
using nanoparticles as well (Wang et al., 2009; Wu et al., 2013). Previous studies have 
determined the average size of the ZnO NPs to be 20nm vs. ~759nm (Wang et al., 2009) 
and 30nm vs. ~627±175 nm (Wu et al., 2013) for TEM vs. zetasizer measurements. 
Particle sizes determined by the zetasizer are measured in terms of hydrodynamic 
diameter, using dynamic light scattering technique. These sizes represent the sizes of NPs 
aggregates in aqueous solutions that mimic its environmental existence forms which was 
tested in this study (Wang et al., 2009). Possible ZnO nanoparticulate was observed in the 
61.4 µM treatment worms in both the gonad region as well as under the cuticle region 
(Fig. 19 A, C, D). No nanoparticulate like objects were observed in any region of the 
control worms (Fig. 19 B). Observing ZnO NPs in the gonad region of the treatment 
worms provides evidence that the nanoparticles may possibly be taken up through the 
worm’s cuticle or possibly via the ingested E. coli (Fig. 20). This also provides evidence 
that the NPs can reach the gonad region of the worm and thus this may contribute to the 
observed increases in germ cell apoptosis in the treatment worms.  
 
 
GENERAL METHODS 
C. elegans Treatments and Apoptosis Assays 
ZnO NP suspensions were made in ultrapure water.  N2 strain was synchronized 
and eggs were collected (Brenner, 1974) (Fig. 4) (see detailed methodology for procedure 
process). Eggs were allowed to hatch as L1 worms without food. N2 L1s will be kept at 
20° C on an NGM agar medium with OP50 as food source.  For the treatment, agar dose 
plates were made by mixing ZnO NP or ZnCl2 solution into the agar medium to make 
various concentrations (6.14×10-1, 61.4, 614 μM ZnO NP and ZnCl2). Approximately 50 
L1 stage worms were transferred to NGM agar plates for the control (unexposed worms 
of the same living conditions), with OP50 (E.coli and luria broth) as a food source. For 
the treatment, approximately 50 L1 stage worms were transferred onto each ZnO NP and 
ZnCl2 dose plate with OP50 as a food source. Exposure time for both treatment and 
control was from the L1 to the adult stage which was ~ 72 hr. There were 3 biological 
replicates for each concentration of ZnO NPs and ZnCl2 treatments. Following exposure 
worms were washed with M9 solution, transferred into microfuge tubes and a SYTO 12 
assay was performed following a standard protocol (Gumienny et al., 1999) (0.75 μl of 
SYTO 12 in 100 μl of M9).  Microfuge tubes were wrapped in aluminum foil due to light 
sensitivity of the SYTO dye.  After 1 hour of staining microfuge tubes were centrifuged 
and supernatant discarded. 1 ml of PTW (1x PBS, 0.1% Tween 20) was added to the 
tubes, tubes were centrifuged, and supernatant discarded.  Worms were transferred to 
fresh NGM agar plates with OP50 for 1 hour to allow the dye to exit intestines.  
Following the 1 hour transfer, a few worms at a time were individually placed on glass 
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slides with 2% agar pads and 5mM levamisole for viewing under a fluorescence 
microscope.  Apoptotic cells were counted and recorded (Fig. 10, 11, and 12). This 
experiment was repeated using the TJ-1 (CEP-1 mutant) strain and ZnO NP dose plates 
of the same concentrations (Fig. 13, 14). 
The MD701 strain was also used to determine apoptotic cell number using the 
exact same method as above. After synchronization worms were dosed using the same 
technique and method described above and dose plates were made using the same method 
above to make a concentration of 61.4 and 614 μM ZnO NP with 3 biological replicates. 
For the control, approximately 50 worms were used. For the treatment approximately 50 
worms were transferred to each 61.4 μM and 614 μM ZnO NP dose plate. Worms were 
dosed from L1 to adult stage. These worms incorporate the GFP gene on ced-1 and 
therefore do not require a staining procedure. After dosing worms were transferred to 
microscope slides with agar pads and levamisole for viewing. Engulfments were counted 
and recorded for each worm (Fig. 7, 8). This experiment using the MD701 strain was 
repeated once more using ZnCl2 (Zn
2+) which serves as a comparison of toxicity with 
ZnO NPs (Fig. 7, 9).  
Gene Expression 
For gene expression, there were 5 biological replicates each group. Five NGM 
plates were made and over 2,000 L1 worms were plated onto each plate. Dosing plates 
described above were made (6.14×10-1 μM ZnO NP) and over 2,000 L1 worms were 
plated onto each plate. Both treatment and control plates were incubated at 20 °C for ~ 65 
to 72 hours (L1-early adult). Each plate was then washed several times into respected 
 
 
15ml falcon tubes. The tubes were centrifuged and washed with M9 3×. After 
washing and centrifuging, supernatant was discarded and worm pellets were transferred 
into microfuge tubes. Tubes were then centrifuged, supernatant discarded, and the final 
worm pellets were frozen using liquid nitrogen and stored in a -80°C freezer until time 
for RNA extractions. RNA extractions were performed (see detailed methodology for 
procedure process) on each of the 10 frozen tubes of worms (5 controls and 5 treatments). 
RNA quality of each tube was measured using a Nanodrop machine and based on results 
I chose the 4 best control tubes and the 4 best treatment tubes. Next, I performed reverse 
transcription (see detailed methodology for procedure process) and quantitative real time 
polymerase chain reaction (qRT-PCR) (see detailed methodology for procedure process) 
on the 8 remaining tubes. This experiment was repeated using the same method described 
above, using different dose concentrations for the treatment (61.4 μM and 614 μM ZnO 
NP) and a different incubation/exposure time (24 hours) (Fig. 15). This gene expression 
experiment was repeated once more using ZnCl2 (614 μM Zn), exposure time was 24 
hours (Fig. 16). 
DETAILED METHODOLOGY 
Synchronization Process 
The synchronization and collection process is as follows, NGM plates containing 
the N2 worms were washed 4x with M9 solution and the worms in the M9 were 
transferred into 15 ml centrifuge tubes.  These tubes were centrifuged, supernatant 
discarded, and 5 ml M9 added, then centrifuged again.  This step was repeated 2 more 
times to wash the worms.  After the third wash the supernatant was discarded, 5 ml of 
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synchronization solution (NaOH and bleach) was added, and tubes were gently hand 
shaken for approximately 5 minutes.  Tubes were then centrifuged, supernatant discarded, 
5 ml of M9 added, and tubes centrifuged again.  The synchronization process will split 
open and degrade all of the worms, killing them, and leaving behind eggs that were both 
inside and outside of the body to be collected (Fig. 4).  The remaining eggs inside the 
tubes with M9 will be incubated at 20° C on a shaker for approximately 16 hours, where 
they will hatch as L1s.   
RNA Extraction 
 RNA was extracted using a mirVANA miRNA isolation Kit. To begin, each of 
the 10 frozen tubes containing all the worms were thawed on ice for approximately 10 
minutes. 600 μl of Lysis/Binding Buffer was added to all 10 tubes and each tube was 
sonicated, to disrupt and homogenize the tissue, using an ultrasonic converter on ice. 
Following sonication, 60 μl of miRNA homogenate additive was added to each tube and 
each tube was vortexed for 30 seconds and placed on ice for 10 minutes. After ice 
incubation, each tube received 600 μl of Acid-Phenol Chloroform then vortexed for 60 
seconds. Tubes were then centrifuged for 5 minutes (10.000 rpm) and the aqueous phase 
of each tube was transferred into 10 new 2 ml centrifuge tubes (this process was repeated 
X2). The final aqueous phase of each tube was transferred into a new tube and 1.25 
volume of 100% ethanol was then added to each tube. Each of the lysate/ethanol mixtures 
were then transferred to filter cartridges in new tubes and centrifuged for ~15 seconds 
(10,000 rpm). Each filter cartridge of each tube was then washed with miRNA wash 
solution 1 and 2/3 provided in kit. Next, each filter cartridge of each tube was transferred 
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into new tubes and 50 μl of pre-heated (95°C) nuclease-free water was applied to each 
filter. Each tube containing filter cartridges were then centrifuged for 5 seconds (5,000 
rpm) to recover RNA product. Finally, each RNA product was quantified using a 
NanoDrop ND-100 spectrophotometer and immediately stored in the -80 ºC freezer until 
time for reverse transcription. 
Reverse Transcription (RT-PCR) 
 After NanoDrop analysis of the RNA samples, I chose the 4 best treatment and 4 
best control RNA samples to use for RT-PCR (8 tubes). RT-PCR was performed using a 
TaqMan® MicroRNA Reverse Transcription Kit. 8 new 0.5 ml microfuge tubes were 
collected. Several calculations were made to determine how much nuclease free water, 
RNA sample, and master mix would be added to each the microfuge tubes. The master 
mix contained calculated volumes of components provided by the kit (RNase inhibitor, 
100 mM dNTPs, 10X Reverse Transcription Buffer, Multiscribe™ Reverse 
Transcriptase, and primer mix (not provided in kit)). After each tube received calculated 
volumes of nuclease-free water, RNA sample, and the master mix, the tubes were mixed 
gently and centrifuged for 10 seconds (200 rpm). The tubes were then incubated on ice 
for 5 minutes and loaded into the thermal cycler for reverse transcription. The thermal 
cycler process includes 30 minutes at 16°C, 30 minutes at 42°C, 5 minutes at 85°C, and 
will hold at 4°C. After RT-PCR, each tube, now containing RT product or cDNA, was 
removed from the thermal cycler and each tube received 80 μl of DNase-free water. The 
tubes were then mixed by vortexing and immediately stored at -20°C until needed for 
qRT-PCR.  
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Quantitative Real-Time PCR (qRT-PCR) 
 To perform qRT-PCR I first placed my previously made RT-PCR products and 
purchased SYBR® Green dye on ice to thaw. Using a 384-well plate microplate, 
following a written template, I loaded each individual well with 5.5 μl RNase DNase-free 
water, 7.5 μl SYBR® Green dye, and 1 μl RT-PCR product. I then loaded each well with 
1 μl of primer solution (20 μl forward, 20 μl reverse, 60 μl water) specific to the genes of 
interest. For each RT-PCR product there were 3 technical replicates. Once the plate was 
fully loaded it was covered and sealed tightly with a film to prevent evaporation of any 
well samples. The plate was then centrifuged to ensure each sample mixture is settled on 
the bottom of each well. Next, the plate was loaded into the qRT-PCR machine to 
undergo one 10 minute cycle at 95°C (enzyme activation), and 45 PCR cycles including 
15 secconds at 95°C (denaturation of DNA), and 60 seconds at 60°C (DNA annealing 
and extension). 
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